Office establishment

Office establishment

Office establishmentDüsseldorf Priavoid established an office at the Life Science Center, Düsseldorf, Germany. News & Events: Office establishment6. März 2020 09th BIO.NRW Business Angel Congress3. März 2020 BIO-EUROPE SPRING 20203. März 2020 AD/PD 202014. Februar...
BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020

BIO-EUROPE SPRING 2020March 23rd – 25th, 2020 Learn more Priavoid participated at the BIO-Europe Spring. News & Events: Office establishment6. März 2020 BIO-EUROPE SPRING 20203. März 2020 Seed Investment6. Mai 2019 CEOs of Priavoid3. Mai 2019 Prof....
Seed Investment

Seed Investment

Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with...
CEOs of Priavoid

CEOs of Priavoid

CEOs of Priavoid 21st February 2019: Dr. Antje Willuweit and Dr. Sabine Willbold became CEOs of Priavoid. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize...
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures November 14th, 2017 Learn more Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed...